First experience of combined enzyme replacement therapy and hematopoietic stem cell transplantation in alpha‐mannosidosis
American Journal of Medical Genetics Part A · 2023
DOI: 10.1002/ajmg.a.63210 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2023. Verfasst von Lucia Santoro und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatrics, Department of Clinical Sciences, Azienda Ospedaliero Universitaria delle Marche, Presidio Salesi, Ancona, Italy. Hauptthemen laut MEDLINE: alpha-Mannosidosis, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
We describe the first case of bridge therapy in alpha‐mannosidosis (AM) in an infant diagnosed at only 5 months of life who underwent enzyme replacement therapy (ERT) in the pre‐ and peri‐transplant phases. Eight ERT infusions were administered before hematopoietic stem cell transplantation (HSCT) and continued for additional 90 days until complete engraftment. The clinical and laboratory data after 3 years post‐HSCT show that the early combined intervention may reduce the disease progression and the urine and plasma content of mannosyl‐oligosaccharides (OS) monitored by liquid chromatography tandem mass spectrometry (LC–MS/MS). This report highlights that early diagnosis and prompt initiation of such treatments in AM are the best chance to minimize the progression of symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatrics, Department of Clinical Sciences, Azienda Ospedaliero Universitaria delle Marche, Presidio Salesi, Ancona, Italy.
- Regional Coordinator Centre for Rare Diseases, Academic Hospital "Santa Maria della Misericordia", Udine, Italy.
- The Division of Pediatric Gastroenterology and Nutrition and Center for Celiac Research, Mass General Hospital for Children, Boston, Massachusetts, USA.
- Department of Pediatric Hematology and Oncology and Cell and Gene Therapy, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.
- Department of Life Sciences and Public Health, Catholic University of the Sacred Heart, Rome, Italy.
ORCID-Profile: Lucia Santoro, Chiara Monachesi
Zitieren
APA
Santoro, L., Monachesi, C., Zampini, L., Padella, L., Galeazzi, T., Santori, E., Cordiali, R., Dardis, A., Catassi, C., Boccieri, E., Galaverna, F., & Locatelli, F. (2023). First experience of combined enzyme replacement therapy and hematopoietic stem cell transplantation in alpha‐mannosidosis. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63210
Vancouver
Santoro L, Monachesi C, Zampini L, Padella L, Galeazzi T, Santori E, et al. First experience of combined enzyme replacement therapy and hematopoietic stem cell transplantation in alpha‐mannosidosis. American Journal of Medical Genetics Part A. 2023. doi:10.1002/ajmg.a.63210
BibTeX
@article{Santoro2023,
author = {Santoro, Lucia and Monachesi, Chiara and Zampini, Lucia and Padella, Lucia and Galeazzi, Tiziana and Santori, Elena and Cordiali, Rosanna and Dardis, Andrea and Catassi, Carlo and Boccieri, Emilia and Galaverna, Federica and Locatelli, Franco},
title = {First experience of combined enzyme replacement therapy and hematopoietic stem cell transplantation in alpha‐mannosidosis},
journal = {American Journal of Medical Genetics Part A},
year = {2023},
doi = {10.1002/ajmg.a.63210}
}
EUVIMED